working doctor photo

Pioneering the Future of Medicinal Cannabis

Tilray Europe

Tilray is one of the global leading companies in the production and research of medical cannabis. In Europe, Tilray, as a medicinal cannabis pioneer, is building an infrastructure to support the thousands of patients across the continent. We’re in the middle of a global paradigm shift regarding knowledge of medical cannabis and Tilray is researching patient use in multiple conditions. Through our evidence-based approach we will ensure Tilray’s medicinal products in Europe are available as regulatory approvals are achieved. Headquartered in Germany, Tilray Europe has team members across the continent, most notably in Portugal where we hold a significant footprint to grow and process medical cannabis. Our GMP-certified production facility in Cantanhede is among the most advanced in the world.



countries on five continents

man icon man icon man icon man icon man icon man icon man icon man icon man icon man icon man icon man icon

patients worldwide


sqm cultivation space in Canada and Portugal

Our 4 Pillars For Success


Tilray’s experience is unmatched worldwide. Our team of professionals on the ground on 5 continents serves tens of thousands of patients around the globe. Our GMP-certified cultivation and production facilities are among the most advanced in the world.


Tilray is the first GMP-certified medical cannabis producer to supply cannabis flower and extracts. All of our products are developed with meticulous care to ensure the highest quality, consistency and purity for patients around the world.


We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities around the globe to advance the clinical applications of cannabinoids.


Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of patients.

Geographic Reach

As laws and regulations regarding medical cannabis evolve in different jurisdictions, we are actively seeking to expand our operations around the world for the benefit of our patients.


Precisely Formulated Products

Tilray produces a wide range of cultivars to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried flower. Each can be administered or consumed via a variety of methods. We take a scientific approach to product development. Our product line focuses on active ingredients and standardized, well-defined preparations. We use formulations and delivery formats that are intended to allow for consistent and measured dosing, and we test all of our products for potency and purity. Each of our commercial products is developed with comprehensive analysis and thorough documentation, including stability profiles, certificates of analysis, monographs and drug master files.

  • Whole flower medical cannabis: Tilray cultivates more than 50 strains to meet patient needs in THC-dominant, CBD-dominant or balanced varieties.
  • Ground flower medicinal cannabis: Milled medical cannabis in THC-dominant, CBD-dominant or balanced varieties.
  • Full-spectrum medical cannabis oral solutions: Tilray medicinal cannabis oral solutions are produced in THC-dominant, CBD-dominant or balanced varieties. The extracts can be used in a dropper or taken as a capsule.
  • Purified medical cannabis oral solutions: Tilray purified oral solutions and capsules undergo a state-of-the-art cold extraction process designed to preserve cannabinoid and terpene content, delivering a pure, aromatic and effective pharmaceutical-grade product.
  • Clinical Compounds: Tilray is proud to partner with world-leading hospitals and universities to develop and produce precisely crafted study drugs to study the efficacy of medicinal cannabis for a variety of conditions.

Advancing Cannabinoid Science

For the therapeutic value and risks of cannabinoid-based medicines to be fully understood, Tilray believes it is critical to evolve current scientific understanding of the field. Our clinical research program is designed with that in mind. Participation in clinical trials is a differentiating element of our research and development program. We have developed techniques that achieve clinical grade isolates in order to facilitate participation in clinical trials conducted by select research partners at world-leading hospitals and universities.